We are the people

Here you can connect and read few words about our proud AIRC Start-up Unit team – who we are, what we are proud of, aspirations and future plans!

Elisa Giovannetti
Elisa Giovannetti
Principal InvestigatorMy research is focusing on the study of the mechanism of action, toxicity and efficacy of anticancer agents, as well as in the field of clinical pharmacology of chemotherapeutic drugs, including modeling of pharmacogenetic studies, mostly in pancreas and lung cancer…
Find out more »

Niccola Funel
Niccola Funel
BiologistMy research is focusing on the establishment and study of primary cancer cell cultures as well as on novel technologies for the analysis of pancreatic cancer tissues, including laser-microdissection. I am also member of the European Pancreatic Club and American Pancreas Club since 2009…
Find out more »

Leticia G. León
Leticia G. León
BioinformaticianMy research is focusing on the analysis of genetic data, including data obtained by next-generation sequencing. I am working as Responsible of the Bioinformatics Unit at the Cancer Pharmacology Lab, funded by the AIRC iCARE Fellowship…
Find out more »

Il nostro team al completo

Team picture, Cancer Pharmacology Lab, Pisa, October 2014, Dr. Giovannetti (PI), with the oncologist Sara Caponi, the surgeon Fabio Caniglia, the biologist Niccola Funel, and the student Edvige Puglisi

 

PhDs and clinical fellows participating to collaborative studies with our team

Daniela Massinhia
Daniela Massinhia
Role of mTOR and Akt pathway in triple negative breast cancer and pancreatic cancer

Ingrid Garajova
Ingrid Garajova
MicroRNA as predictive an prognostic biomarkers in solid tumors

Rocco Sciarrillo
Rocco Sciarrillo
Splicing alterations as novel mechanism of drug resistance

Tessa Le Large
Tessa Le Large
Phosphoproteomics for therapy response prediction in pancreatic cancer

Laura Meijer
Laura Meijer
Novel diagnostic and predictive biomarkers in liquid biopsies for peri-ampullary tumors

Chiara Caparello
Chiara Caparello
Folfirinox in pancreatic cancer: clinical and translational studies towards personalized tratements

Nele van der Steen
Nele van der Steen
New drug combinations and biomarkers for therapies targeting c-Met and EGFR in Non-Small Cell Lung cancer